GGrantIndex
← Leaderboards

Lukasz Pawel Gondek

Johns Hopkins University

$3,151,101
Attributed
$3,151,101
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $581.1K · FY201725
$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,151,101 · 3

By mechanism

R01$2,046,875 · 1
K08$858,600 · 1
R21$245,626 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Frequencies

Research focus

FrequenciesGeneticElderlyCellsLeukemiaTumorDysmyelopoietic SyndromesMalignant NeoplasmsInferiorSelf-RenewalHematopoiesisIn VivoLeukemogenesisHematologyEpigenetic ProcessOncogenicPathway InteractionsInsightHematopoietic Stem CellsMalignant - DescriptorPublishingAge-YearsBloodAffect

Grant awards (12)

The Biological Consequences of Age-related Clonal Hematopoiesis$409,375
R01 · FY2025 · HL · contact PI
The Biological Consequences of Age-related Clonal Hematopoiesis$409,375
R01 · FY2024 · HL · contact PI
The Biological Consequences of Age-related Clonal Hematopoiesis$409,375
R01 · FY2023 · HL · contact PI
The Biological Consequences of Age-related Clonal Hematopoiesis$409,375
R01 · FY2022 · HL · contact PI
The Biological Consequences of Age-related Clonal Hematopoiesis$409,375
R01 · FY2021 · HL · contact PI
Hedgehog Signaling in the Progression of Myelodysplastic Syndromes$171,720
K08 · FY2021 · HL · contact PI
Hedgehog Signaling in the Progression of Myelodysplastic Syndromes$171,720
K08 · FY2020 · HL · contact PI
Hedgehog Signaling in the Progression of Myelodysplastic Syndromes$171,720
K08 · FY2019 · HL · contact PI
Personalized molecular approaches to disease monitoring and maintenance therapies for Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) patients undergoing allogeneic bone marrow transp$122,813
R21 · FY2019 · HL · contact PI
Hedgehog Signaling in the Progression of Myelodysplastic Syndromes$171,720
K08 · FY2018 · HL · contact PI
Personalized molecular approaches to disease monitoring and maintenance therapies for Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) patients undergoing allogeneic bone marrow transp$122,813
R21 · FY2018 · HL · contact PI
Hedgehog Signaling in the Progression of Myelodysplastic Syndromes$171,720
K08 · FY2017 · HL · contact PI